Search

everythinglearnresearchcommunity

for

Search:↓

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Ripretinib is effective and safe for treating advanced GIST in Chinese patients, particularly for non-gastric GISTs.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

Type I interferons play a key role in the development of various skin diseases.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Fetal wounds heal without scarring because of different biological factors, which could help improve adult wound healing.

Wnt5a slows down hair growth by blocking a specific pathway during hair regeneration.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Only skin melanocytes, not other types, can color hair in mice.

The research found ways to activate melanocyte stem cells for potential treatment of skin depigmentation conditions.

Removing Sprouty genes in mice causes various hormone-related issues but does not increase cancer risk by one year of age.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

MPA increases cancer spread by boosting Eph A2 activity.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

ATP helps prevent skin damage from vandetanib by reducing stress.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Hair greying is seen as a sign of aging; temporary fixes like hair dye are used, but a balanced diet and hair care can help manage it.

The document concludes that skin stem cells are important for hair growth and wound healing, and could be used in regenerative medicine.

Targeting colon cancer stem cells might lead to better treatment results.

Planarian regeneration begins with a specific gene activation caused by injury, essential for healing and tissue regrowth.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.